Back to Search Start Over

The CCK-2 receptor agonist Lu-177-PP-F11N for PRRT of medullary thyroid cancer – Recent results of the phase 1 “LUMED” Study

Authors :
Rottenburger, C
Nicolas, G
McDougall, L
Fürstner, M
Hentschel, M
Kaul, F
Christ, ER
Cachovan, M
Vija, HA
Schibli, R
Geistlich, S
Béhé, M
Wild, D
Source :
Nuklearmedizin. Nuclear medicine; April 2021, Vol. 60 Issue: 2
Publication Year :
2021

Details

Language :
English
ISSN :
00295566
Volume :
60
Issue :
2
Database :
Supplemental Index
Journal :
Nuklearmedizin. Nuclear medicine
Publication Type :
Periodical
Accession number :
ejs55778229
Full Text :
https://doi.org/10.1055/s-0041-1726707